U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07439003) titled 'Behavioral Risk Identification and Decision Guidance for HIV Engagement' on Feb. 19.
Brief Summary: Despite much progress towards reaching UNAIDS goals for HIV treatment, disengagement from care remains one of the biggest obstacles to HIV elimination. In many African countries, including South Africa, the early treatment period (first six months after starting or re-starting antiretroviral therapy (ART)) is the interval with the highest risk of treatment interruption and disengagement, but until recently, this period had received relatively little attention from researchers and policy makers. The Retain6 project was launched in 2021...